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Background: Vibrio cholerae is a facultative pathogen that lives in the aquatic environment and the human host. The
ability of V. cholerae to monitor environmental changes as it transitions between these diverse environments is vital to
its pathogenic lifestyle. One way V. cholerae senses changing external stimuli is through the three-component signal
transduction system, VieSAB, which is encoded by the vieSAB operon. The VieSAB system plays a role in the inverse
regulation of biofilm and virulence genes by controlling the concentration of the secondary messenger, cyclic-di-GMP.
While the sensor kinase, VieS, and the response regulator, VieA, behave similar to typical two-component phosphorelay
systems, the role of the auxiliary protein, VieB, is unclear.
Results: Here we show that VieB binds to VieS and inhibits its autophosphorylation and phosphotransfer activity thus
preventing phosphorylation of VieA. Additionally, we show that phosphorylation of the highly conserved Asp residue
in the receiver domain of VieB regulates the inhibitory activity of VieB.
Conclusion: Taken together, these data point to an inhibitory role of VieB on the VieSA phosphorelay, allowing for
additional control over the signal output. Insight into the function and regulatory mechanism of the VieSAB system
improves our understanding of how V. cholerae controls gene expression as it transitions between the aquatic
environment and human host.
Keywords: Two-component system, Phosphorelay, Bacterial signal transduction, Protein phosphorylation,
Phosphodiesterases, Tetratricopeptide repeat domain, Vibrio choleraeBackground
Vibrio cholerae is a human small intestinal pathogen that
causes profuse secretory diarrhea and vomiting leading
to severe dehydration, which if left untreated can result
in death. Upon ingestion of V. cholerae from a contami-
nated water source, this pathogen travels to the small in-
testine where expression of the toxin coregulated pilus
results in colonization and subsequent expression of
virulence genes, such as cholera toxin (CT). Transloca-
tion of CT into the epithelial cells lining the small intes-
tine leads to profuse secretory diarrhea and results in
the exit of V. cholerae from the host back into the
aquatic environment [1-4]. The lifestyle of V. cholerae
involves two drastically different environments, the* Correspondence: andrew.camilli@tufts.edu
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unless otherwise stated.aquatic environment and the small intestine of the hu-
man host. For optimal fitness, V. cholerae must be able
to sense these environmental changes and it therefore
harbors an array of systems that link environmental
stimuli to gene expression changes. Bacteria commonly
use two-component systems (TCS) to sense a wide var-
iety of environmental cues and transmit this information
intracellularly [5-7]. Additionally, given that some bac-
teria, like V. cholerae, endure dramatic environmental
changes as they enter the human host, a number of
TCSs have been shown to play a role in bacterial patho-
genesis [8-11].
V. cholerae has served as a model organism for studying
signal transduction and regulation of virulence genes. One
way V. cholerae senses changing environments is through
the VieSAB signal transduction system, which was previ-
ously discovered through a genetic screen for virulence
gene regulators [12]. VieSAB is encoded in a putativel. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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a complex sensor kinase (SK) containing two putative
periplasmic ligand-binding domains and cytoplasmic histi-
dine kinase (HK), receiver domain (REC) and histidine
phosphotransferase domains (Hpt). VieS is capable of
autophosphorylating and uses the complex phosphorelay
system to transfer phosphate to the response regulator
(RR), VieA [13]. VieA resembles a traditional RR, contain-
ing an N-terminal REC domain and C-terminal helix-
turn-helix (HTH) domain. However, VieA is unusual in
also harboring a cyclic-di-GMP (cdGMP) phosphodiester-
ase (PDE) domain that lies between the REC and HTH
domains [12]. V. cholerae uses VieA to modulate its intra-
cellular cdGMP concentration in order to regulate gene
expression during the transition between the aquatic en-
vironment and the human host [14,15]. Lowering the con-
centration of cdGMP early during infection promotes
expression of virulence and motility genes and leads to re-
pression of environmental survival genes, namely biofilm
formation genes [16,17]. Indeed, VieS and VieA have been
implicated in the negative regulation of biofilm formation,
are required for the colonization of the infant mouse, and
are important for the positive regulation of the CT genes
(ctxAB) and a major virulence gene transcriptional regula-
tor (toxT), highlightening the role of VieSAB in modulat-
ing V. cholerae pathogenesis [13-15,18,19]. Additionally,
vieA transcription is shown to increase significantly after
the binding of V. cholerae to epithelial cells, supporting
the hypothesis that VieA is a major contributor to cdGMP
cleavage early during infection and is capable of influen-
cing gene expression through this mechanism [20]. These
studies point to a role of VieSAB in tying together the
sensing of external stimuli with changes in the cytoplas-
mic cdGMP concentration, allowing V. cholerae to adapt
as it transitions between the environment and the host.
However, the role of the third component in the Vie-
SAB system, VieB, remains unclear. While VieB contains
an N-terminal REC domain, it lacks the typical RR C-
terminal HTH domain. Instead, it contains a tetratrico-
peptide repeat domain, which mediates protein-protein
interactions, followed by a C-terminal half of the protein
that has no known sequence homology, providing little
insight into the function of this protein. Since a majority
of well-studied auxiliary proteins have been described as
inhibitors [21], we hypothesize that VieB acts as an in-
hibitor of the VieSA TCS. In this study, we uncover and
characterize the function of VieB and reveal its mechan-
ism of action.
Results
VieB is a dose-dependent inhibitor of VieA-His6
phosphorylation
Since many other described auxiliary proteins of TCSs
negatively modulate their cognate TCS, we hypothesizedthat VieB functions as an inhibitor of the VieSA TCS. To
test this we examined the effect of VieB on phospho-
transfer between GST-VieS-C (GST-tagged cytoplasmic
portion of VieS) and VieA-His6. In vitro phosphotransfer
between an MBP-VieS-C fusion protein and VieA-His6
was previously demonstrated [13]. Using purified GST-
VieS-C, we found that autophosphorylation and phospho-
transfer to VieA-His6 behaves as expected (Figure 1A).
When a five-fold molar excess of VieB was added to the
reaction, there was a complete loss of the production of
phosphorylated VieA-His6 (Figure 1A). VieB does not be-
come readily phosphorylated in this assay even though it
harbors a Rec domain, suggesting VieB does not act as a
phosphate sink or compete with VieA-His6 for phosphor-
ylation. However, our data so far cannot rule out the pos-
sibility that VieB may harbor high phosphatase activity,
which could result in no observable phosphorylated VieB
if it is a phosphatase of itself. Together, these data show
that VieB is an inhibitor of phosphotransfer between
GST-VieS-C and VieA-His6.
To examine whether VieB functions enzymatically, we
varied its molar ratio relative to GST-VieS-C and P-
VieA-His6 and measured phosphorylation of each pro-
tein. As seen in Figure 1B, while VieA-His6 is readily
phosphorylated in the absence of VieB, as the VieB con-
centration increases, there was a correlative decrease in
the amount of P-VieA-His6. At equal molar amounts,
VieB was able to reduce the amount of P-VieA-His6 by
approximately 50% (Figure 1B, lane 4). When VieB is in-
creased to twice the molar amount, there was further
loss of P-VieA-His6. Total inhibition occurred only when
VieB was in molar excess over GST-VieS-C and VieA-
His6 (Figure 1B, lane 7). In contrast, the amount of
phosphorylated GST-VieS-C was largely unchanged in
the reactions except for a modest decrease at the highest
concentration of VieB (Figure 1B, lane 7). Taken to-
gether, these data suggest that VieB inhibition of VieA
phosphorylation is dose-dependent and is not enzymatic.
VieB inhibits VieS autophosphorylation and
phosphotransfer
To address the role of VieB in its ability to inhibit auto-
phosphorylation of VieS, phosphotransfer experiments
were conducted over time in the absence of VieA-His6.
As seen in Figure 2A, wild-type GST-VieS-C was able to
autophosphorylate in the presence of five-fold molar ex-
cess (5 μM) VieB, though the total amount of phosphor-
ylation was lower (Figure 2A-B). These data could
suggest that VieB is weakly affecting autophosphoryl-
ation. Alternatively, since VieS has three phosphorylation
sites along its phosphorelay, it is also possible that VieB
could block the intra-molecular phosphotransfer. If VieB
blocks at the first or second site, the total amount of ac-





















Figure 1 VieB is a dose-dependent inhibitor of phosphotransfer. (A) Purified GST-VieS-C was incubated with 32P-ATP-γ either alone (lane 1) or in
the presence of equimolar VieA-His6 (lane 2) and 5 μM VieB (lane 3) for 30 minutes at 30°C. (B) GST-VieS-C was incubated with 32P-ATP-γ in the presence
of equimolar VieA-His6 and either 0, 0.25, 0.5, 1, 2, 4, or 8 μM VieB for 30 minutes at 30°C. Samples were stopped with the addition of 2X-
denaturing sample buffer and separated using a 10% SDS-Page gel. Proteins labeled with 32P were observed by radioautography. Figure
panels are from the same experiment and exposed for the same amount of time. The radioautographs shown are a representative of three
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Figure 2 VieB moderately inhibits VieS-C autophosphorylation. Purified GST-VieS-C or MBP-VieS-C D1018A was incubated with 32P-ATP-γ in the
presence or absence of 5 μM VieB over time at 30°C. Samples were stopped at indicated time points with the addition of 2X-denaturing sample buffer
and separated using a 10% SDS-Page gel. GST-VieS-C labeled with 32P were observed by radioautography (A,C) and quantified in (B,D).The radioautograph
shown is a representative of three replicates. Error bars represent the SEM of three replicates.
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autophosphorylation of the HK domain, we used an intra-
molecular phosphorelay mutant of VieS-C in the auto-
phosphorylation assay. An MBP-VieS-C D1018A mutant
was constructed that has the conserved Asp residue in the
REC domain replaced with an Ala, rendering it only able
to autophosphorylate at the HK domain while transfer be-
tween the REC-Hpt domains and the final transfer to
VieA-His6 are disrupted. As seen in Figure 2C, while
MBP-VieS-C D1018A was able to rapidly autophosphory-
late to high levels over time in the absence of VieB; when
VieB was present, the amount of autophosphorylation is
significantly reduced (Figure 2C-D). Furthermore, the rate
of autophosphorylation was lessened in the presence of
VieB, confirming that VieB does inhibit VieS autophospho-
rylation, though it is not complete.
Since VieB is only able to partially inhibit GST-VieS-C
autophosphorylation, yet can completely block phospho-
transfer between VieS and VieA, we hypothesize that
VieB must also be affecting either the VieS intra-mo-
lecular phosphorelay or phosphotransfer from the VieS
Hpt domain to VieA. To test this hypothesis, the inhibi-
tory effect of VieB on phosphotransfer between GST-
VieS-C and VieA-His6 was observed in the absence of
ATP. In order to specifically address phosphotransfer in
the absence of autophosphorylation, ATP was removed
from the reaction after GST-VieS-C was robustly phos-
phorylated to prevent further autophosphorylation. As
seen in Figure 3, phosphorylated GST-VieS-C was able
to transfer phosphate to VieA-His6 in the absence of
ATP. However, when VieB was present, the amount of
P-VieA-His6 was greatly reduced (Figure 3). This sug-
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Figure 3 VieB inhibits VieS intra-molecular phosphotransfer. Purified G
and VieB for 30 minutes at 30°C. Excess 32P-ATP-γ was removed from phos
then incubated with additional MnCl2 and either buffer, 1 μM VieA-His6 or
stopped at indicated time points with the addition of 2X-denaturing samp
labeled with 32P were observed by radioautography. The radioautograph sVieS and VieA-His6. While we hypothesize that VieB
may be inhibiting the intra-molecular phosphorelay be-
tween the VieS HK and REC domains, the data pre-
sented here cannot distinguish if VieB is acting intra- or
inter-molecularly.
VieB does not affect the stability of P-VieS-C
Since VieB causes a reduction in the amount of P-VieS-C,
VieB could affect the stability (auto-dephosphorylation) of
P-VieS-C. To test this hypothesis, both wild-type GST-
VieS-C and the mutant MBP-VieS-C D1018A were
allowed to autophosphorylate in the absence of VieB and
then the rate of loss of P-VieS-C was measured over time.
As seen in Figure 4, the addition of VieB did not affect the
loss of phosphate in either the wild-type GST-VieS-C or
the MBP-VieS-C D1018A mutant. These data suggest that
VieB does not alter the stability of phosphate on VieS-C,
ruling out this mechanism of action for VieB.
VieB is neither a phosphatase nor stimulates GST-VieS-C
phosphatase activity
Some auxiliary proteins that negatively modulate TCSs
harbor phosphatase activity [22-24]. Since the addition
of VieB has its most dramatic effect on the amount of P-
VieA-His6, it is possible that VieB is a phosphatase of
VieA-His6. To test this hypothesis, we conducted order
of addition phosphotransfer experiments, where GST-
VieS-C is incubated with either VieA-His6 or VieB prior
to the addition of the other protein. When GST-VieS-C
was first incubated with VieA-His6 and VieB was added
second, P-VieA-His6 was still present, though to a much
lesser degree than when VieB was absent (Figure 5A).
However, some level of P-VieA-His6 remains even in the- - - -
+ + + +
+ + + +
+ + + + + +
+ + + + + +
+ + + + + +
ST-VieS-C was incubated with 32P-ATP-γ in the absence of VieA-His6
phorylated VieS-C constructs by gel filtration. P-VieS-C constructs were
pre-mixed 1 μM VieA-His6 and 5 μM VieB for 60 minutes. Samples were
le buffer and separated using a 10% SDS-Page gel. VieS-C constructs
hown is a representative of three replicates.
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Figure 4 VieB does not affect the stability of phosphorylated GST-VieS-C. Purified GST-VieS-C or MBP-VieS-C D1018A was incubated with
32P-ATP-γ in the absence of VieB for 30 minutes at 30°C. Excess 32P-ATP-γ was removed from phosphorylated VieS-C constructs by gel filtration.
P-VieS-C constructs were then incubated with additional MnCl2 and buffer or with 5 μM VieB for 60 minutes. Samples were stopped at indicated
time points with the addition of 2X-denaturing sample buffer and separated using a 10% SDS-Page gel. VieS-C constructs labeled with 32P were
observed by radioautography (A, B) and quantified in (C).The radioautograph shown is a representative of three replicates. Error bars represent
the SEM of three replicates.
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VieB is either inefficient in or not able to dephosphorylate
P-VieA-His6. In contrast, when GST-VieS-C was incu-
bated with VieB prior to the addition of VieA-His6, there
was no detectable P-VieA-His6 suggesting a complete dis-
ruption of phosphotransfer (Figure 5A). Furthermore,
GST-VieS-C was able to acquire phosphate even when
VieB was present prior to VieA-His6. Taken together,
these data suggest that VieB is not a phosphatase of VieA.
However, the observed reduction in phosphotransfer
could be through the phosphatase activity of the SK.Therefore we next hypothesized that VieB binds GST-
VieS-C and stimulates its phosphatase activity [25-27].
To test this hypothesis, we measured the rate of loss of
radiolabeled P-VieA-His6 over time in the presence of
GST-VieS-C, GST-VieS-C plus VieB, or in buffer alone.
When P-VieA-His6 was incubated with buffer alone,
there was an intrinsic slow rate of loss of phosphate to
water (Figure 5B), which is a common phenomenon
among RRs, though the rate of loss can vary [28,29].
When P-VieA-His6 was incubated with GST-VieS-C or















Figure 5 VieB is not a phosphatase or stimulates GST-VieS-C phosphates activity. (A) Previously described phosphotransfer assays were
conducted at 30°C in the presence of 32P-ATP-γ with the following modifications: Lane 1- GST-VieS-C alone was incubated for 60 minutes, Lane 2-
GST-VieS-C was incubated with 1 μM VieA-His6 for 60 minutes, Lane 3- GST-VieS-C was incubated with 1 μM VieA-His6 for 30 minutes then 5 μM
wild-type VieB was added for an additional 30 minutes, Lane 4- GST-VieS-C was incubated with 5 μM wild-type VieB for 30 minutes then 1 μM VieA-
His6 was added for an additional 30 minutes. Proteins labeled with
32P were observed by radioautography. The radioautographs shown are a
representative of three replicates. (B) 32P-VieA-His6 was incubated with buffer, GST-VieS-C alone or GST-VieS-C and VieB for 60 minutes at 30°C. Samples
were taken over time and quantified. 0 minute time point represents 100% 32P-VieA-His6. Error bars represent the SEM of three replicates.
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(Figure 5B). Therefore these data suggest that GST-
VieS-C does not have phosphatase activity nor does the
presence of VieB stimulate that activity. It should be
noted that in some instances, SK phosphatase activity re-
quires the full-length protein folded properly in a mem-
brane, therefore phosphatase activity of VieS in vivo
cannot be completely ruled out by our data.
Mutation of the conserved Asp residue in the REC domain
affects the inhibitory activity of VieB
In TCSs, the activity of the RR is regulated though the
phosphorylation of a conserved Asp residue in the REC
domain, resulting in activation of the RR and execution
of its output activity. Due to the high sequence hom-
ology of the VieB REC domain to other REC domains
and the presence of the conserved Asp (D62) residue,
we hypothesized that phosphorylation of VieB affects itsinhibitory activity. However, VieB was poorly phosphory-
lated by GST-VieS-C (Figure 1) or acetyl-phosphate
(data not shown); our inability to achieve phosphorylated
VieB presents a challenge for addressing if the inhibitory
activity of VieB is regulated by its phosphorylation state.
Therefore, as substitutes for unphosphorylated and phos-
phorylated VieB, point mutations in vieB were constructed
to replace D62 with either an Ala (D62A), mimicking a
non-phosphorylated state, or a Glu (D62E), which mimics
a phosphorylated state. Of note, while the amount of wild-
type VieB phosphorylation can vary, neither point mutant
ever became phosphorylated during the phosphotransfer
reactions, suggesting that the D62 residue is indeed the
conserved site for phosphorylation and that there is no al-
ternative phosphorylation site in VieB (Figure 6). When
the purified VieB D62A was added to the reaction, this
mutant was able to inhibit phosphotransfer to the same
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Figure 6 Mutation of the conserved Asp residue affects the inhibitory activity of VieB. GST-VieS-C was incubated with 32P-ATP-γ in the presence
of equimolar VieA-His6 (lane 1) and either 5 μM wild-type VieB (lane 2), VieB D62A (lane 3), or VieB D62E (lane 4) for 30 minutes at 30°C. Samples were
stopped with the addition of 2X-denaturing sample buffer and separated using a 10% SDS-Page gel. Proteins labeled with 32P were observed by
radioautography. Figure panels are from the same experiment and exposed for the same amount of time. The radioautographs shown are a
representative of four replicates. Standard deviation is shown below. Stars denotes a significant P-value < 0.05 determine by a Mann–Whitney U test.
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of phosphotransfer to occur between GST-VieS-C and
VieA-His6 (Figure 6). These data suggest that the phos-
phorylation state of VieB affects its ability to inhibit phos-
photransfer, where unphosphorylated VieB is an active
inhibitor while phosphorylated VieB is less active.
VieB interacts with GST-VieS-C
Since VieB prevents phosphorylation of VieA-His6
through the inhibition of GST-VieS-C autophosphoryl-
ation and intra-molecular transfer, we hypothesize that
VieB binds to GST-VieS-C. To address if VieB can inter-
act with GST-VieS-C, GST pull-downs were conducted.
Immobilized GST-VieS-C was able to pull down VieB and
VieA-His6 from whole cell lysate (data not shown). To
characterize this interaction, we used size-exclusion chro-
matography coupled with multi-angle light scattering
(SEC-MALS) and composition-gradient MALS (CG-
MALS) to quantify the self- and hetero-association affinity
and stoichiometry for all combinations of the VieSAB pro-
teins. Table 1 summarizes the results of these experiments.As revealed by the MALS data, VieS-C and VieA-His6 are
both putative homo-dimers, and each VieS-C dimer binds
a single VieA-His6 dimer. The equilibrium dissociation
constant (KD) for this interaction is 1.38 μM. Additionally,
VieB exists as a monomer, and each VieS-C dimer binds a
single VieB monomer, with KD = 0.467 μM. This affinity is
approximately three-fold stronger than that of the VieS-
C/VieA-His6 interaction, which is consistent with VieB be-
ing able to inhibit the VieS-VieA phosphotransfer. Of
note, there were no other stoichiometries present for the
VieB/VieS-C interaction, suggesting that only one VieB
binding site is present on VieS-C. Similar to wild-type
VieB, the VieB D62E point mutant is also a monomer. Un-
expectedly, the VieB D62E, which is a weaker inhibitor of
phosphotransfer, is still able to bind VieS-C at the same
stoichiometry as wild-type VieB with a KD of 0.197 μM.
This affinity is about two-fold stronger than that of wild-
type VieB. There is no detectable interaction between
VieA-His6 and VieB. These data further support the
model that VieB specifically interacts with VieS to inhibit
phosphotransfer.
Table 1 VieB specifically interacts with VieS-C
Protein Combination Native Oligomeric State Hetero-association stoichiometry KD (μM)
VieS-C + VieA-His6 VieS-C VieA-His6 1 dimer : 1 dimer 1.38 ± 0.35
Dimer (MW = 150 kDa) Dimer (MW = 130 KDa)
VieS-C + VieB VieS-C VieB 1 dimer : 1 monomer 0.467 ± 0.054
Dimer (MW = 150 kDa) Monomer (MW = 64 kDa)
VieS-C + VieB D62E VieS-C VieB D62E 1 dimer : 1 monomer 0.197 ± 0.061
Dimer (MW = 150 kDa) Monomer (MW = 64 kDa)
VieA-His6 + VieB VieA-His6 VieB N/A N/A
Dimer (MW = 130 kDa) Monomer (MW = 64 kDa)
Characterization of VieS-C, VieA-His6, wild-type VieB and the VieB D62E point mutant (self-association) were determined by Size-Exclusion Chromatography Multi-
angle Light Scattering. To determine the protein-protein interactions of various VieSAB protein combinations, hetero-association interaction kinetics were determined
over a range of protein concentrations by Composition-gradient Multi-angle Light Scattering. Data for the hetero-association stoichiometry are represented in monomer
units. These data represent the average and ± SD of three independently purified replicates.
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Based on the data presented so far, we propose that VieB
functions as a phosphotransfer inhibitor by preventing
GST-VieS-C autophosphorylation and phosphotransfer,
however the mechanism of inhibition is unclear. Inhibi-
tors are able to block enzymatic activity through two
main mechanisms, competitive or noncompetitive bind-
ing. Previously, MBP-VieS-C was shown to have kinase
activity, operating under second order Michaelis-Menten
kinetics [13]. Therefore, to determine the mechanism of
inhibition by VieB, we generated a Lineweaver-Burk Plot
using phosphotransfer assays. VieB concentrations were
varied to determine the rate (velocity) of phosphotrans-
fer between GST-VieS-C and VieA-His6. Since VieB is a
dose-dependent inhibitor, we expect that GST-VieS-C/Figure 7 VieB is a non-competitive inhibitor. A Lineweaver-Burk Plot was
range of VieA-His6 (2, 4, and 8 μM) and wild-type VieB (0, 4, 8, and 12 μM) con
quantified by radioautography. These data represent the average velocity of t
VieB). V = velocity.VieA-His6 phosphotransfer will decrease as VieB con-
centrations increase. As expected, as the VieB concen-
tration increases, the velocity at which GST-VieS-C can
phosphorylate VieA-His6 decreases. Extrapolation of the
line for each VieB concentration shows that all VieB
concentrations result in the same Michaelis Km (x-inter-
cept) but varying Vmax (y-intercept) (Figure 7). These
data suggest that VieB is a noncompetitive inhibitor of
GST-VieS-C.
VieB does not affect the interaction between GST-VieS-C
and VieA-His6
Given the noncompetitive model of inhibition, we would
expect the binding of VieB to GST-VieS-C to have little
to no effect on the binding ability of VieA-His6 to GST-generated using the previously described phosphotransfer assay over a
centrations. VieA-His6 phosphorylated with
32P (P-VieA-His6) was
hree replicates (0, 4 and 12 μM VieB) and four replicates (8 μM
Mitchell et al. BMC Microbiology  (2015) 15:59 Page 9 of 16VieS-C. To test this hypothesis, GST pull-down experi-
ments with purified proteins were conducted. Since VieB
was most effective at molar concentrations that are
higher than GST-VieS-C and VieA-His6, we chose to
conduct these experiments with VieB at a five-fold molar
excess over VieA-His6, and with both VieA-His6 and
VieB at molar excess over GST-VieS-C. When VieA-
His6 was incubated with GST-VieS-C, VieA-His6 was
pulled down in the elution fraction with GST-VieS-C
(Figure 8, lane 6). Since VieA-His6 was in five-fold molar
excess to GST-VieS-C, it was expected that some VieA-
His6 would be present in the wash fraction (Figure 8,
lane 5). The amount of VieA-His6 that was pulled down
in this elution fraction was quantified and set to 100%.
In the presence of VieB, the amount of VieA-His6 that
was eluted with GST-VieS-C was significantly reduced
by 70% (Figure 8, lane 8). However, BSA was used as a
negative control to test if the addition of a nonspecific
protein at the same five-fold excess molar concentration
can prevent VieA-His6 binding. While there was a smaller
reduction (26%) in the amount of VieA-His6 bound in the
presence of BSA, this decrease is not significantly different
from the decrease seen when VieB is present (as deter-
mine by one-way ANOVA and Dunn’s Multiple Compari-
son), suggesting that the reduction of VieA-His6 in both
reactions are the result of nonspecific interactions. As a
negative control for VieA-His6 and VieB nonspecific inter-
actions with GST, GST alone was immobilized to the
glutathione beads. As seen in Figure 8, lanes 11–14, nei-
ther VieA-His6 nor VieB interact with GST. Taken  1      2        3       4       5         6   










Figure 8 VieB does not disrupt the GST-VieS-C/VieA-His6 interaction. GS
beads were incubated with either, pre-mixed 5 μM VieA-His6 and 25 μM VieB
(BSA). Reactions were washed with 150 μl of wash buffer five times and prote
reduced glutathione. Samples were taken from the input (I), wash (W) and elu
protein stainTM. VieB, VieA and BSA inputs are indicated by lanes 2–4, respecti
standard deviation shown below; gel shown is a representative of the replica
Dunn’s Multiple Comparison. M = protein standard.together, these data support the noncompetitive inhibition
model, whereby the presence of VieB does not affect the
ability of VieA-His6 to bind to GST-VieS-C but prevents
only phosphotransfer.
Discussion
VieSAB plays an important regulatory role in allowing
V. cholerae to adapt to its environment as this pathogen
transitions from the aquatic environment to the small
intestine of the human host. VieSA composes a classical
TCS, where VieS is a complex SK capable of autopho-
sphorylating and engages in phosphotransferwith the
RR, VieA [13]. In this study, we provide biochemical evi-
dence that VieB, the previously uncharacterized third
component in the VieSAB signal transduction system, in-
hibits phosphotransfer to VieA, thus providing a negative
feedback mechanism to down-regulate the VieSA TCS
phosphorelay. We show that VieB accomplishes this in-
hibition by binding to VieS and preventing autophospho-
rylation and phosphotransfer to VieA. Additionally, we
show that mutating the conserved phosphorylation site in
the REC domain can modulate the inhibitory activity of
VieB, where the D62E mutant is a weaker inhibitor than
the wild-type VieB or the D62A mutant.
vieSAB is well-described as an important contributor to
V. cholerae’s control of gene expression during infection.
The ability of VieSAB to modulate virulence gene expres-
sion is achieved through the VieA PDE domain, which hy-
drolyzes the secondary messenger molecule, cdGMP,
during infection [14,15,20]. Changes in intracellular cdGMPW      E W      E 
      7        8        9       10      11      12      13      14     
%          30%            74%
(± 9.5)         (± 11)
W     E W      E 
VieA VieA VieA VieA 
VieB VieB BSA 
T-VieS-C (lane 5–10) or GST alone (lane 11–14) bound to glutathione
(VieB), 5 μM VieA-His6 alone (VieA) or 5 μM VieA-His6 and 25 μM BSA
in was eluted off the beads with 150 μl of elution buffer containing
tion (E) fractions for analysis on 10% SDS Page gel stained with Lumitein
vely. Percentage of VieA-His6 bound is the average of four replicates with
tes. Statistical significance was determined by one-way ANOVA and
Mitchell et al. BMC Microbiology  (2015) 15:59 Page 10 of 16are known to regulate gene expression, where low concen-
trations of cdGMP result in induction of virulence genes
and repression of biofilm genes. Conversely, when cdGMP
levels are high, the inverse is observed for these two classes
of genes. VieA also contains a putative HTH DNA-binding
domain, suggesting that in addition to its PDE activity,
VieA may regulate gene expression through direct DNA
binding, though this has not been shown. A previous
microarray study suggests that VieA is autoregulatory, as a
deletion of vieA resulted in decreased expression of the
entire vieSAB operon when compared to wild type V. cho-
lerae [30]. Taken together with this study, we present a
working model incorporating the role of VieB in nega-
tively regulating the expression of VieA through VieS in-
hibition (Figure 9). Upon VieS binding to an unknown
environmental stimulus, VieS autophosphorylates at the
HK domain, transfers the phosphate intra-molecularly, in
order to phosphorylate the REC domain of VieA. Given
VieA’s suggested autoregulatory activity, we propose that
phosphorylation of VieA results in its activation as a tran-
scription factor, triggering an increase in vieSAB expres-
sion. This up-regulation increases the quantity of VieA in
the cytoplasm resulting in reduction of cdGMP concentra-
tion through enzymatic hydrolysis by the VieA PDE do-
main. This decrease in the intracellular level of cdGMP
helps trigger expression of virulence genes needed for sur-
vival in the host (Figure 9A).
Over time, autoregulation of the vieSAB operon results
in accumulation of VieB. We hypothesize that VieB is able
to tightly bind VieS as a noncompetitive inhibitor, ultim-
ately preventing additional phosphotransfer to VieA. We
propose that this disruption of VieA phosphorylation is
due to VieB binding at or near the HK domain of VieS
and inhibiting both its autophosphorylation and intra-
molecular transfer of phosphate to its REC domain.
Phospho-VieA levels are then presumably reduced, shut-
ting off or at least down-regulating expression of the
vieSAB operon and virulence genes due to increasing
cdGMP levels (Figure 9B). Since VieB appears to be a
moderate inhibitor of autophosphorylation, it is possible
for some VieS to acquire phosphate at the HK domain,
even in the presence of VieB. Therefore, if VieS be-
comes phosphorylated, the ability of VieB to not only
prevent further autophosphorylation but also disrupt
the transfer of the already bound phosphate ensures that
VieA does not become phosphorylated.
Negative feedback regulation is not uncommon among
TCSs. Indeed, other TCS have incorporated auxiliary pro-
teins in order to inhibit the phosphosignalling between
the SK and RR. For example, in B. subtilis, numerous aux-
iliary proteins negatively control the progression of phos-
photransfer in a TCS that controls sporulation [22-24].
The inhibitors Sda and KipI interact with the SK, KinA,
binding to the HK domain to block autophosphorylation,specifically the transfer of phosphate from ATP to the His
residue. However, neither block phosphotransfer to the
RR nor dephosphorylate the SK [23,31]. In addition to Sda
and KipI, Rap proteins and Spo0E act as phosphatases at
various stages in the phosphotransfer and dephosphory-
late two important RRs, Spo0F and Spo0A. Another ex-
ample of inhibition by auxiliary proteins is modulation of
the SK, NtrB, by the PII nitrogen-sensor protein in the
NtrBC TCS in E. coli [32]. NtrBC is involved in the as-
similation of ammonia and metabolism of alternative
nitrogen-containing compounds. NtrB has dual functions,
harboring both kinase and phosphatase activities, where
the directional flow of phosphate depend on its interaction
with PII. When PII is bound to NtrB, this promotes phos-
phatase activity on the RR, NtrC. Conversely, when PII is
not interacting with NtrB, this allows NtrC to act as a kin-
ase to phosphorylate NtrC [33]. We show that VieB inter-
acts specifically with the SK, VieS, however our data
suggest that VieB is neither a phosphatase nor does it
modulate the phosphatase activity of VieS. While the
function of VieB appears similar to the Sda and KipI in-
hibitors in B. subtilis, our data provide evidence that is
also capable of blocking either the intra-molecular phos-
phorelay or phosphotransfer to VieA. Therefore, we be-
lieve that the ability of VieB to specifically block both
autophosphorylation and phosphotransfer provides a
novel mechanism for the negative regulation of TCS.
Our data suggests that the inhibitory activity of VieB
may be regulated, which to our knowledge is a novel
mechanism for regulating an auxiliary inhibitor of a TCS.
Just as the activity of traditional RRs is controlled by the
phosphorylation of the REC domain, it appears that VieB
also may be controlled by this same mechanism. However,
for traditional RRs, phosphorylation leads to activation,
whereas for VieB, phosphorylation (mimicked by the
D62E mutation) leads to inactivation. This reverse regula-
tion by phosphorylation is an attractive model for an in-
hibitor like VieB: Since VieB in its unphosphorylated state
is able to bind VieS and is active for inhibition, phosphor-
ylation of VieB can then serve as a shut-off signal, allow-
ing VieS to regain function. Intriguingly, the D62E mutant
retains strong binding to VieS. This suggests that the mere
binding of VieB to VieS is not sufficient for inhibition, but
that the structure of VieB that is bound plays an import-
ant role. However, we cannot rule out the possibility that
the D62E mutant fails to mimic the phosphorylated form
of VieB adequately.
Conclusions
Our work presented here biochemically characterizes
the role of VieB in the VieSA TCS. We show that VieB
binds to the VieS sensor kinase and blocks phospho-
transfer to the VieA response regulator and cdiGMP
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Figure 9 Proposed model for VieB inhibition. Stimulation of the VieSA TCS by binding of external signal (stars) to VieS results in autophosphorylation
and phosphotransfer to and activation of VieA. We propose that VieA activation results in the amplification of the vieSAB operon and up-
regulation of virulence genes. We hypothesize that this up-regulation of vieA, leads to decreased intracellular levels of c-di-GMP and enhanced
expression of virulence genes (A). Over time, or at high levels of transcription of the vieSAB operon, VieB accumulates. This pool of VieB is able
to tightly bind, noncompetitively, to VieS. We hypothesize that this binding disrupts autophosphorylation and the transfer of phosphate between the HK
and REC domains of VieS, down-modulating the phosphorelay. This lack of phosphotransfer to VieA results in down regulation of vieSAB and virulence
genes (B). ‘X’ denotes the inhibitory action of VieB. Black arrows correspond to active phosphotransfer while grey arrows denote incompletion of transfer.
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TCS, allowing for tight regulation over VieA activity and
subsequent cdGMP levels. This further highlights therole of this TCS in modulating gene expression in V.
cholerae and provides a more comprehensive under-
standing of how VieSAB functions. Future work is
Mitchell et al. BMC Microbiology  (2015) 15:59 Page 12 of 16necessary for elucidating structural details of the inter-
action between VieB and VieS, as well as the precise
conditions under which VieB is active. Insight into how
VieSAB modulates the inverse expression of virulence
and environmental genes may aid in the understanding
of how and when V. cholerae regulates its complex viru-
lence cascade as it transitions from the aquatic environ-
ment into the host.
Methods
Growth conditions and strain construction
All strains used in this study are listed in Table 2. All PCR
primers used are listed in Table 3. Bacteria were grown in
Luria-Bertani broth supplemented with 100 μg/ml
ampicillin at 37°C with aeration. 1 mM isopropyl-β-D-
thiogalactopyranoside (IPTG) was added when necessary
to induce protein expression. The cytoplasmic encoding
portion of vieS (vieS-C) and full-length vieB (vieB) were
constructed using PCR amplicons made from V. cholerae
strain O395 template DNA. For glutathione S-transferase
(GST) tagged vieS-C, a silent mutation was created at the
internal NdeI restriction endonuclease recognition site at
position 2916. This mutant allele was generated by overlap
extension PCR [34] using primer pairs GST-VieS-C F/
GST-VieS-C T2916C R and GST-VieS-C T2916C F/GST-
VieS-C R. vieB was generated by PCR using the VieB F/R
primers. The outer primers for each of these alleles intro-
duce NdeI and BamHI restriction sites for subsequent
cloning. After amplification, PCR products were double-
digested with NdeI and BamHI (New England Biolabs).
Generation of the GST-vieS-C was ligated into a modified
pGEX vector that includes a TEV protease recognition site
after the GST tag [6]. vieB was ligated into a modified
pET15b plasmid that also includes a TEV recognition site
after the poly-Histidine (His6) tag [6]. The maltose binding
protein (MBP) tagged vieS-C D1018A mutant was gener-
ated using overlap extension PCR using the primer pairs
MBP-VieS-C F/MBP-VieS-C D1018A R and MBP-VieS-C
D018A F/MBP-VieS-C R. Specifically for MBP-vieS-C
D1018A, the outer primers introduced a BamHI and SalI
restriction sites for subsequent cloning. Generation of the
MBP-vieS-C D1018A was ligated into the pMALc2ETable 2 Bacterial strains and plasmids used in this study
Strain Description
AC50 V. cholerae classical O395 biotype
AC4713 E. coli BL21 (DE3) pGEX-TEV::vieS-C
AC4714 E. coli BL21 (DE3) pMMB67eh::vieA-His6
AC4715 E. coli BL21 (DE3) pET15b-TEV::His6-vieB
AC4716 E. coli BL21 (DE3) pET15b-TEV::His6-vieB D62A
AC4717 E. coli BL21 (DE3) pET15b-TEV::His6-vieB D62E
AC4002 E. coli BL21 (DE3) pMalc2E-TEV::vieS-Cvector. Ligations were transformed into E. coli DH5α by
electroporation and plated on Luria-Bertani broth supple-
mented with ampicillin. The insert in each plasmid was
confirmed by DNA sequencing. The pMMB67EH::vieA-
His6 was purified from DH5α and transformed into E. coli
BL21 (DE3) for protein expression [35]. The VieB D62
point mutants were constructed using the QuickChange
site-directed mutagenesis method (Stratagene) using the
pET15b::His6-vieB vector. The mutations were confirmed
by DNA sequencing, and the plasmids were transformed
into E. coli BL21 (DE3) for protein expression.
Protein expression and purification
E. coli BL21 (DE3) containing the protein expression vec-
tors were grown in 1 L cultures to an OD600 = 0.5-0.8.
Protein expression was induced by the addition of 1 mM
IPTG and grown at 20°C for 17 hours. 1 L cell cultures
were harvested by centrifugation at 2, 990 × g for 20 mi-
nutes and resuspended in 25 ml of the following buffers:
for GST-VieS-C and MBP-VieS-C D1018A, 20 mM Tris
pH = 8, 150 mM NaCl, 5 mM beta mercaptoethanol
(βME), Complete EDTA-free protease inhibitor cocktail
tablet (Roche); and for VieA-His6, His6-VieB, and His6-
VieB D62 mutants, 20 mM Tris pH = 8, 150 mM NaCl,
25 mM Imidazole, 5 mM βME, Complete EDTA-free pro-
tease inhibitor cocktail tablet (Roche). The resuspended
cells were lysed on ice with five, 30-second pulses (0.5 sec-
onds on, 0.5 second off) of sonication at 50% amplitude
with one-minute rest in between pulses. Cell debris was
pelleted by centrifugation at 38, 464 × g for 45–60 mi-
nutes at 4°C and the supernatant was collected.
For GST-VieS-C, supernatant was incubated on 7 ml
of Glutathione Sepharose 4B beads (GE Healthcare) for
30 minutes at 4°C. The beads were washed with three
column volumes of 20 mM Tris pH = 8, 200 mM NaCl,
5 mM βME. Protein was eluted in 30 ml of 100 mM Tris
pH = 8, 20 mM reduced glutathione, 100 mM NaCl,
5 mM βME. For VieS-C, the GST tag was removed by
the addition of TEV protease overnight at 4°C. Both
GST-VieS-C and VieS-C were diluted three-fold with
Buffer A (20 mM Tris pH = 8, 1 mM DTT) and applied





His6-VieB D62A This study
His6-VieB D62E This study
MBP-VieS D1018A 13
Table 3 Primers used in this study
Primer Name Primer Sequence 5′ − 3′
GST-VieS-C F tcactgtgcatatgactgagcagctacgttggttgacgg
GST-VieS-C R gagcgagtcggatcctcagagataacgactgagtactttgcgc
GST-VieS-C T2916C F gttgattactgactgccacatgccacatcttgatg
GST-VieS-C T2916C R catcaagatgtggcatgtggcagtcagtaatcaac
VieB F tcactgtgcatatggctgtacctacttttgctgaattaaaag
VieB R gagcgagtcggatccttacgcctcaactgattcgcttcgc
VieB D62A F gatttgatatttttatttgcgcttacaacttcggtaaggggtt
VieB D62A R aaccccttaccgaagttgtaagcgcaaataaaaatatcaaatc
VieB D62E F gatttgatatttttatttgcgagtacaacttcggtaaggggtt
VieB D62E R aaccccttaccgaagttgtactcgcaaataaaaatatcaaatc
MBP-VieS-C F CGCGGATCCTTACGCAGCTCCGAACAAG
MBP-VieS-C R ACGCGTCGACTTATTCGCTCTGATACTGATG
MBP-VieS-C D1018A F TATGGCAATTGGTAATCAACAAATCATACTGCTCAGGATGTTGCGAGAGCTTTT
MBP-VieS-C D1018A R CGAAAAGCTCTCGCAACATCCTGAGCAGTATGATTTGTTGATTACCAATTGCCA
All primers are listed 5′ to 3′. Italics indicate restriction enzymes used for cloning.
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Protein was eluted using a 0-50% (v/v) Buffer B (20 mM
Tris pH = 8, 1 M NaCl, 1 mM DTT) gradient developed
over 15 column volumes, with protein eluting around
33% (v/v). The peak fractions were pooled and concen-
trated by centrifugation at 2,514 × g at 4°C using the
Amicon Ultra-15 10 K centrifugal filters (Millipore). Pro-
tein was then applied to a Superose12 prep grade 16/70
gel filtration (GE Healthcare) column that was equili-
brated in Gel Filtration Buffer (25 mM Tris pH = 7.5,
100 mM KCl, 1 mM DTT, 5% glycerol (v/v)). For VieS-
C, peak fractions were pooled and incubated a second
time on 2 ml of Glutathione Sepharose 4B beads equili-
brated in Gel Filtration Buffer for 30 minutes at 4°C to
remove any remaining GST tag or GST-VieS-C protein.
Flow-through containing VieS-C was collected and
concentrated.
For MBP-VieS-C D1018A, supernatant was incubated
on 5 ml of amylose high flow resin (New England Bio-
labs) for 30 minutes at 4°C. Beads were washed with five
column volumes of 20 mM Tris pH = 8, 150 mM NaCl,
5 mM βME and eluted in 30 ml of 20 mM Tris pH = 8,
100 mM NaCl, 1 mM DTT and 30 mM maltose. Protein
was diluted three-fold with Buffer A and applied to a
4 ml Source15Q anion exchange column. MBP-VieS-C
D1018A was eluted using a 0-50% (v/v) Buffer B gradi-
ent developed over 15 column volumes, eluting around
31% (v/v). The peak fractions were pooled, concentrated
and applied to a Superose12 prep grade 16/70 gel filtra-
tion column equilibrated in Gel Filtration Buffer.
For VieA-His6, His6-VieB and His6-VieB D62 point
mutants, supernatant was incubated on 7 ml of His-Pur
NiNTA beads (Thermo Scientific) for 30 minutes at 4°C.
Beads were washed three times with three columnvolumes of Wash 1 (20 mM Tris8, 150 mM NaCl,
25 mM imidazole, 5 mM βME), three times with three
column volumes of Wash 2 (same as Wash 1 except
50 mM imidazole), and eluted in 30 ml of Elution Buffer
(same as Wash 1 except 300 mM imidazole). For VieB
and the D62 point mutants, the His tag was removed by
the addition of TEV protease overnight at 4°C. Proteins
were diluted three-fold with Buffer A and applied to a
4 ml Source15Q anion exchange column. VieA-His6 was
eluted using a 0-40% (v/v) Buffer B gradient (eluting
around 23% (v/v)) while VieB and the D62 mutants were
eluted using a 0-35% (v/v) Buffer B gradient (eluting
around 20% (v/v)), both developed over 15 column vol-
umes. The peak fractions were pooled, concentrated,
and applied to a Superose12 prep grade 16/70 gel filtra-
tion column equilibrated in Gel Filtration Buffer.
Phosphotransfer assays
Phosphotransfer reactions were carried out as described
by Martinez et al. [13] with the following modifications.
Phosphotransfer reactions were incubated in phospho-
transfer buffer (Gel Filtration Buffer supplemented with
5 mM MnCl2, 25 μM radiolabeled
32P-ATP-γ [10 mCi/
ml; Perkin Elmer, Boston, MA] and 1.25 μM cold ATP).
GST-VieS-C, MBP-VieS-C D1018A and VieA-His6 were
at final concentrations of 1 μM while VieB and the D62
mutants were at a final concentration of 5 μM, unless
stated otherwise. Once reactions were stopped by the
addition of 2X denaturing sample buffer (10 mM Tris
pH = 6.8, 4% (w/v) SDS, 20% (v/v) glycerol, bromophenol
blue, βME), proteins were separated on 10% SDS-PAGE
gel at 200 V for 45 minutes. Time course experiments
were stopped at indicated time points shown. Autoradio-
graphs were recorded and quantified with FUJI FILM
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Multi-Gauge software (Life Science). Due to inherent ex-
perimental variation, an internal control of GST-VieS-C
and VieA-His6 phosphotransfer in the absence of VieB is
included with every experiment.
Phosphorylated VieS stability assay
1 μM GST-VieS-C or MBP-VieS-C D1018A was incu-
bated with 25 μM 32P-ATP-γ for 30 minutes at 30°C. To
remove excess ATP, phosphorylated VieS-C (P-VieS-C)
constructs were passed through a Performa DTR spin
gel filtration column (EdgeBio) for two minutes at 750 ×
g. Additional MnCl2 was added and Gel Filtration Buffer
or 5 μM VieB was added to P-VieS-C constructs and in-
cubated at 30°C. The amount of P-VieS-C was measured
over time. At indicated time points, reactions were
stopped and analyzed as previously described for the
phosphotransfer assays.
Phosphorylated VieS transfer assay
1 μM GST-VieS-C was incubated with 25 μM 32P-ATP-
γ for 30 minutes at 30°C. To remove excess ATP, P-
VieS-C constructs were passed through a Performa DTR
spin gel filtration column (EdgeBio) for two minutes at
750 × g. Additional MnCl2 was added and then either
Gel Filtration Buffer, 1 μM VieA-His6, 5 μM VieB or
pre-mixed 1 μM VieA-His6 and 5 μM VieB was added
to P-VieS-C and incubated at 30°C. The amount of P-
VieS-C was measured over time. At indicated time
points, reactions were stopped and analyzed as previ-
ously described for the phosphotransfer assays.
VieS phosphatase assay
GST-VieS-C was bound to Glutathione Sepharose 4B
beads equilibrated in phosphotransfer buffer. Beads were
washed and VieA-His6 was added in the presence of
25 μM radiolabeled 32P-ATP-γ and incubated for 30 mi-
nutes at 30°C. Beads were washed three times with
150 μl of 25 mM Tris pH = 7.5, 150 mM KCl, 1 mM
DTT by centrifugation for 30 seconds at 12, 000 × g
using Pierce Spin Columns (Thermo Scientific) to collect
phosphorylated VieA-His6 (P-VieA-His6). P-VieA-His6
was incubated with new GST-VieS-C alone or GST-
VieS-C plus VieB in phosphotransfer buffer in the ab-
sence of [32P-γ]. Samples were collected over time and
reactions were analyzed and quantified using the de-
scribed method above for the phosphotransfer assays.
Lineweaver-Burk plot
Phosphotransfer assays described above were used to
generate the Lineweaver-Burk plot except VieA-His6
concentrations ranged from 2–8 μM and VieB concen-
trations ranged from 0–12 μM while GST-VieS-C
remained constant (1 μM). Samples were taken at 0, 3.5,7.5, and 15 minutes. The amount of phosphorylated
VieA-His6 was quantified over time in order to generate
enzyme reaction velocities at each concentration com-
bination. A double reciprocal plot was generated by plot-
ting the inverse of the enzyme reaction velocity against
the inverse of VieA-His6 (substrate) concentration using
GraphPad Prism5 (GraphPad). Extrapolation of each line
to determine the intercept was determined by linear re-
gression analysis.Multi-angle light scattering
Size-exclusion chromatography coupled with multi-angle
light scattering (SEC-MALS) was used to determine oligo-
meric state of each protein. SEC-MALS was conducted
using the ÄKTA HPLC Explorer system (GE Healthcare)
connected to a vacuum degasser (Alltech), a Superose12
10/300 GL gel filtration (GE Healthcare) column equili-
brated in 0.1 μm filtered Gel Filtration Buffer that is dir-
ectly connected to a DAWN HELEOS II light scattering
detector (Wyatt Technology Corporation) and an Optilab
T-rEX refractive index detector (Wyatt Technology Cor-
poration). The column temperature was held at 4°C while
light scattering detection was conducted at 25°C. A MALS
baseline was established with Gel Filtration Buffer over-
night. Light scattering and concentration data were ac-
quired and analyzed with ASTRA software (version 6,
Wyatt Technology Corporation) to determine molar mass
in solution, and thus oligomeric sate, of each protein. All
light scattering experiments were conducted using the un-
tagged VieS-C protein, which is able to dimerize in the ab-
sence of the GST tag.
Composition gradient MALS (CG-MALS) was con-
ducted to probe the hetero-association interactions be-
tween various combinations of the VieSAB proteins
[36-38]. The Calypso II syringe pump system (Wyatt
Technology Corporation) was used to inject various pro-
tein concentration mixtures to the DAWN HELEOS II
light scattering detector that was attached to the UV
detector of the ÄKTA HPLC Explorer system (GE
Healthcare). The Gel Filtration Buffer was used for all
CG-MALS and was filtered through a 0.1 μm filter. Pro-
teins were diluted into this Gel Filtration Buffer at a pre-
determined stock concentration and were subsequently
filtered through a 0.02 μm filter. After each injection,
the flow was stopped for 30–180 seconds to allow protein
interactions to reach equilibrium. Hetero-association stoi-
chiometry, and dissociation constants (KD) were deter-
mined using the CALYPSO software (version 2.1.3, Wyatt
Technology Corporation) based off the light scattering
and UV signal acquired during the stopped flow for
each concentration gradient. All CG-MALS experi-
ments were conducted using the same untagged VieS-C
protein used in SEC-MALS.
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Unconjugated GST tag, used as a negative control for
purified protein GST pull-downs, was purified as fol-
lows: TEV protease was added to previously purified
GST-VieS-C overnight at 4°C. The sample was incubated
on 500 μl of Glutathione Sepharose 4B beads that were
equilibrated in Gel Filtration Buffer for 30 minutes at 4°
C. Beads were washed and eluted as described above for
GST-VieS-C. Protein was directly applied to a HiLoad
16/60 Superdex75 prep grade gel filtration (GE Health-
care) column to separate GST alone from any un-
cleaved GST-VieS-C protein. The peak fractions corre-
sponding to GST tag alone were collected and used for
subsequent experiments.
For pull-downs, 1 μM of either GST-VieS-C or GST tag
was incubated on 50 μl Glutathione Sepharose 4B beads
for 30 minutes at 4°C using Pierce Spin Columns. Bound
protein was washed three times with 150 μl of 25 mM
Tris pH = 7.5, 150 mM KCl, 1 mM DTT by centrifugation
for 30 seconds at 12, 000 × g. 5 μM VieA-His6 that was
premixed with either buffer, 25 μM VieB, or 25 μM BSA
was incubated on the beads for 15 minutes at 30°C. Reac-
tions were washed five times each with three column vol-
umes of 25 μM Tris pH= 7.5, 100 mM KCl, 1 mM DTT
using the same centrifugation conditions. An additional
dry spin was conducted to ensure all of the wash was re-
moved from the column. GST-VieS-C or GST and all
bound proteins were eluted using 150 μl of the elution
buffer described above for GST-VieS-C purification. Sam-
ples from the input, wash and elution fractions were
taken, 2X denaturing sample buffer was added, and were
analyzed by 10% SDS-PAGE gel that was stained with
Lumitein protein stain™. Gel images were acquired using
the FUJI FILM Image Reader FLA-9000 and protein
bands were quantified using FUJI FILM Multi-Gauge
software.
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